The Espirit scaffold treats chronic limb-threatening ischemia (CLTI) below the knee (BTK). Abbott designed it to keep ...

Commenting on the launch of the coronary stent system, Tushar Sharma, general manager for Abbott’s vascular business in India ...

Abbott announced that the FDA has approved the transcatheter Esprit BTK everolimus-eluting resorbable scaffold system for the ...

First-of-its-kind, Esprit BTK Everolimus Eluting Resorbable Scaffold System is designed to keep treat chronic ...

Abbott introduces XIENCE Sierra stent system in India, offering advanced features to treat complex cardiovascular cases ...

The surge in demand for angioplasty balloons and stents is mainly driven by the increasing prevalence of cardiovascular ...

The US Food and Drug Administration has approved Esprit BTK everolimus-eluting scaffold system for chronic limb-threatening ...

The Global Peripheral Drug Eluting Balloons Market is Undergoing Sizable Expansion with Increasing Demand for Minimally ...

Abbott has returned to the field of bio-absorbable, dissolving stents, and in somewhat uncharted territory. | Abbott has ...

NPPA revises ceiling price of coronary stents in tune with WPI growth: Gireesh Babu, New Delhi Friday, May 3, 2024, 08:00 Hrs [IST] The National Pharmaceutical Pricing Authority ( ...

The approval marks the return of the dissolving-scaffold concept, which so far has failed to find success in the coronaries.

Indians are also known to have a high prevalence coronary artery disease (CAD) or blockages of the arteries at 21.4 percent ...